These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9544501)

  • 1. [A system of nonspecific defense in chronic inflammatory bowel diseases--pathophysiologic and therapeutic aspects].
    Lügering N; Kucharzik T; Stoll R; Domschke W
    Z Gastroenterol; 1998 Feb; 36(2):173-87. PubMed ID: 9544501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current concept of the role of monocytes/macrophages in inflammatory bowel disease--balance of proinflammatory and immunosuppressive mediators.
    Lügering N; Kucharzik T; Stoll R; Domschke W
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):338-44. PubMed ID: 9759608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical distribution and serum levels of the Ca(2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease.
    Lügering N; Stoll R; Kucharzik T; Schmid KW; Rohlmann G; Burmeister G; Sorg C; Domschke W
    Digestion; 1995; 56(5):406-14. PubMed ID: 8549885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis.
    Frosch M; Strey A; Vogl T; Wulffraat NM; Kuis W; Sunderkötter C; Harms E; Sorg C; Roth J
    Arthritis Rheum; 2000 Mar; 43(3):628-37. PubMed ID: 10728757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
    Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
    J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The calcium-binding proteins MRP8 and MRP14 form a membrane-associated heterodimer in a subset of monocytes/macrophages present in acute but absent in chronic inflammatory lesions.
    Bhardwaj RS; Zotz C; Zwadlo-Klarwasser G; Roth J; Goebeler M; Mahnke K; Falk M; Meinardus-Hager G; Sorg C
    Eur J Immunol; 1992 Jul; 22(7):1891-7. PubMed ID: 1378023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of combined treatment with IL-10 and IL-4, but not IL-13, for inhibition of monocyte release of the Ca(2+)-binding protein MRP8/14.
    Lügering N; Kucharzik T; Lügering A; Winde G; Sorg C; Domschke W; Stoll R
    Immunology; 1997 May; 91(1):130-4. PubMed ID: 9203976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An increased number of CD40-high monocytes in patients with Crohn's disease.
    Sawada-Hase N; Kiyohara T; Miyagawa J; Ueyama H; Nishibayashi H; Murayama Y; Kashihara T; Nakahara M; Miyazaki Y; Kanayama S; Nezu R; Shinomura Y; Matsuzawa Y
    Am J Gastroenterol; 2000 Jun; 95(6):1516-23. PubMed ID: 10894589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and complex formation of S100-like proteins MRP8 and MRP14 by macrophages during renal allograft rejection.
    Goebeler M; Roth J; Burwinkel F; Vollmer E; Böcker W; Sorg C
    Transplantation; 1994 Aug; 58(3):355-61. PubMed ID: 7519798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical demonstration of the calcium-binding proteins MRP8 and MRP14 and their heterodimer (27E10 antigen) in Crohn's disease.
    Schmid KW; Lügering N; Stoll R; Brinkbäumer P; Winde G; Domschke W; Böcker W; Sorg C
    Hum Pathol; 1995 Mar; 26(3):334-7. PubMed ID: 7890287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K
    Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The myeloic related protein MRP8/14 (27E10 antigen)--usefulness as a potential marker for disease activity in ulcerative colitis and putative biological function.
    Lügering N; Stoll R; Schmid KW; Kucharzik T; Stein H; Burmeister G; Sorg C; Domschke W
    Eur J Clin Invest; 1995 Sep; 25(9):659-64. PubMed ID: 7498239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical study of colonic mucosa macrophages in children with Crohn's disease and ulcerative colitis].
    Rodrigues M; Zerbini MC; Barbieri D
    Arq Gastroenterol; 1998; 35(4):283-91. PubMed ID: 10347713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
    Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
    Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane.
    Youssef P; Roth J; Frosch M; Costello P; Fitzgerald O; Sorg C; Bresnihan B
    J Rheumatol; 1999 Dec; 26(12):2523-8. PubMed ID: 10606357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?
    Saniabadi AR; Hanai H; Suzuki Y; Ohmori T; Sawada K; Yoshimura N; Saito Y; Takeda Y; Umemura K; Kondo K; Ikeda Y; Fukunaga K; Nakashima M; Beretta A; Bjarnason I; Lofberg R
    J Clin Apher; 2005 Oct; 20(3):171-84. PubMed ID: 15892107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
    Banks C; Bateman A; Payne R; Johnson P; Sheron N
    J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
    Nakase H; Okazaki K; Tabata Y; Chiba T
    J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.
    Ten Hove T; The Olle F; Berkhout M; Bruggeman JP; Vyth-Dreese FA; Slors JF; Van Deventer SJ; Te Velde AA
    J Leukoc Biol; 2004 Jun; 75(6):1010-5. PubMed ID: 15020649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients.
    Szkaradkiewicz A; Marciniak R; Chudzicka-Strugała I; Wasilewska A; Drews M; Majewski P; Karpiński T; Zwoździak B
    Arch Immunol Ther Exp (Warsz); 2009; 57(4):291-4. PubMed ID: 19578817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.